Public health approach to emerging infections among pregnant women.
As public health professionals respond to emerging infections, particular attention needs to be paid to pregnant women and their offspring. Pregnant women might be more susceptible to, or more severely affected by, emerging infections. The effects of a new maternal infection on the embryo or fetus are difficult to predict. Some medications recommended for prophylaxis or treatment could harm the embryo or fetus. We discuss the challenges of responding to emerging infections among pregnant women, and we propose strategies for overcoming these challenges.
Rasmussen
Sonja A
SA
Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. skr9@cdc.gov
Hayes
Edward B
EB
D000890:Anti-Infective Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007114:Immunization; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy; D015980:Public Health Practice; D014481:United States / Q000453:epidemiology
D000890:Anti-Infective Agents